Letter to the editor: Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD
Yuan Qin, Anqi Li, Bilin Liu, Meng Gao, Guohua Gong – 30 April 2022
Yuan Qin, Anqi Li, Bilin Liu, Meng Gao, Guohua Gong – 30 April 2022
Hannes Hagström – 30 April 2022
Jun Zhou, Yongkun Sun, Wen Zhang, Jiajia Yuan, Zhi Peng, Wei Wang, Jifang Gong, Lin Yang, Yanshuo Cao, Hong Zhao, Chao Chen, Weifeng Wang, Lin Shen, Aiping Zhou – 30 April 2022
AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a committee of hepatology experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.
AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.
Patient guidelines are adaptations and patient-friendly summaries of published AASLD Guidances which are written specifically for patients to help them understand their liver disease. Clinicians may also provide these patient guidances to their patients as a resource during consultations.
Richard X. Sousa Da Silva, Achim Weber, Philipp Dutkowski, Pierre‐Alain Clavien – 29 April 2022 – Although liver transplantation is a true success story, many patients still die awaiting an organ. The increasing need for liver grafts therefore remains an unsolved challenge to the transplant community. To address this, transplant donor criteria have been expanded and, for example, more liver grafts with significant steatosis or from donors with circulatory death are being used.
Ruben Hernaez, Fasiha Kanwal – 28 April 2022
Chanda Ho, Marina Serper – 28 April 2022
Brian Kim, Norah A. Terrault – 28 April 2022